Drug interactions
Insulin degludec-liraglutide + Pioglitazone
Severity: Moderate
Insulin degludec-liraglutide and Pioglitazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pioglitazone improves insulin sensitivity, and combining it with insulin and a GLP-1 receptor agonist increases the glucose-lowering effect and the risk of hypoglycemia. Insulin with a thiazolidinedione also raises the risk of fluid retention and edema, and heart failure in susceptible patients.
What this interaction means in plain words
Insulin degludec-liraglutide and Pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Insulin degludec-liraglutide belongs to Endocrine; Pioglitazone belongs to Endocrine.
Why it happens
Additive pharmacodynamic glucose lowering through different mechanisms (insulin sensitization, insulin replacement and incretin effect).
What to do
Monitor blood glucose and reduce the insulin dose if hypoglycemia occurs. Watch for edema, weight gain and signs of heart failure.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin degludec-liraglutide and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Insulin degludec-liraglutide
Other interactions of Pioglitazone
Frequently asked questions
Can I take Insulin degludec-liraglutide with Pioglitazone?
MediHelp rates the interaction as moderate. Insulin degludec-liraglutide and Pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pioglitazone improves insulin sensitivity, and combining it with insulin and a GLP-1 receptor agonist increases the glucose-lowering effect and the risk of hypoglycemia. Insulin with a thiazolidinedione also raises the risk of fluid retention and edema, and heart failure in susceptible patients.
How serious is the interaction between Insulin degludec-liraglutide and Pioglitazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and reduce the insulin dose if hypoglycemia occurs. Watch for edema, weight gain and signs of heart failure.
What other medicines interact with Insulin degludec-liraglutide?
MediHelp also lists interactions of Insulin degludec-liraglutide with, for example, Albiglutide, Chlorpropamide, Clozapine. The full list is on the Insulin degludec-liraglutide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
